SFM
PMN icon

Sphera Funds Management’s ProMIS Neurosciences PMN Stock Holding History

Sphera Funds Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Hold
325,591
– – 0.56% 62
2026
Q1 		$4.14M Buy
325,591
+313,784
+2,658% +$4.68M 0.66% 55
2025
Q4 		$80.6K Hold
11,807
– – 0.02% 98
2025
Q3 		$125K Sell
11,807
-64,165
-84% -$888K 0.03% 112
2025
Q2 		$919K Sell
75,972
-1,200
-2% -$16.4K 0.22% 90
2025
Q1 		$1.34M Hold
77,172
– – 0.31% 81
2024
Q4 		$1.83M Hold
77,172
– – 0.33% 82
2024
Q3 		$2.41M Buy
77,172
+4,603
+6% +$172K 0.38% 74
2024
Q2 		$2.72M Sell
72,569
-793
-1% -$37.1K 0.37% 75
2024
Q1 		$3.5M Hold
73,362
– – 0.49% 60
2023
Q4 		$2.11M Hold
73,362
– – 0.34% 71
2023
Q3 		$3.69M Buy
+73,362
New +$4.77M 0.67% 50

Other funds holding PMN

JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sphera Funds Management's PMN Position: Q2 2026 in Review

Sphera Funds Management held its ProMIS Neurosciences (PMN) position steady in Q2 2026 at 325,591 shares worth $4.28M. The position accounts for 0.56% of the portfolio, ranked #62.

Sphera Funds Management first reported a position in PMN in Q3 2023 and has held it in 12 quarters since. 27 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

  • Sphera Funds Management held 325,591 shares of ProMIS Neurosciences worth $4.28M as of Q2 2026.
  • Sphera Funds Management left its ProMIS Neurosciences share count unchanged in Q2 2026.
  • ProMIS Neurosciences made up 0.56% of Sphera Funds Management's portfolio in Q2 2026, its #62 holding.
  • Sphera Funds Management first reported a position in ProMIS Neurosciences in Q3 2023 and has held it in 12 quarters since.
  • 27 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.